Severe Cysticercal Meningitis: Clinical and Imaging Characteristics

被引:12
作者
Cardenas, Graciela [1 ]
Jung, Helgi
Rios, Camilo
Fleury, Agnes
Luis Soto-Hernandez, Jose
机构
[1] Inst Nacl Neurol & Neurocirug, Dept Neuroinfectol, Mexico City 14269, DF, Mexico
关键词
NEUROCYSTICERCOSIS; SECONDARY;
D O I
10.4269/ajtmh.2010.09-0347
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In disease-endemic areas, severe cysticercal meningitis (SCM) is characterized by intense inflammatory cerebrospinal fluid (CSF) and negative bacterial and fungal Cultures. There have been no systematic studies of SCM. We characterized patients with SCM and compare them with neurocysticercosis (NC) patients with mild CSF abnormalities by conducting a nine-year retrospective review at a neurological referral center. Two groups of patients were compared: group A, those with severe CSF pleocytosis > 1,000 cells/mm(3) (n = 12), and group B, those with CSF pleocytosis <= 1,000 cells/mm(3) (n = 126). All patients had positive CSF results in an enzyme-linked immunosorbent assay for cysticercal antigens and negative CSF cultures for bacteria, fungi, and mycobacteria. Intracranial hypertension, meningeal signs, CSF hypoglycorrachia, and a longer clinical course of NC were more frequently seen in group A. It is likely that SCM often goes unrecognized. Its correct identification may reduce morbidity and risks of unnecessary surgery ill patients with chronic NC and CSF shunts.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 33 条
[1]   EXTRAPARENCHYMAL NEUROCYSTICERCOSIS - REPORT OF 5 CASES AND REVIEW OF MANAGEMENT [J].
BANDRES, JC ;
WHITE, AC ;
SAMO, T ;
MURPHY, EC ;
HARRIS, RL .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :799-811
[2]   NEUROCYSTICERCOSIS [J].
BARRY, M ;
KALDJIAN, LC .
SEMINARS IN NEUROLOGY, 1993, 13 (02) :131-143
[3]  
Bittencourt P R, 1990, Arq Neuropsiquiatr, V48, P286
[4]  
Bonametti Ana Maria, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P27, DOI 10.1590/S0036-46651994000100005
[5]  
BRUTTO OHB, 1988, ARCH INTERN MED, V148, P544
[6]  
Castillo-Iglesias H, 2006, J Infect, V53, pe35, DOI 10.1016/j.jinf.2005.09.005
[7]  
Cheillan D, 1999, ANN BIOL CLIN-PARIS, V57, P356
[8]   Proposed diagnostic criteria for neurocysticercosis [J].
Del Brutto, OH ;
Rajshekhar, V ;
White, AC ;
Tsang, VCW ;
Nash, TE ;
Takayanagui, OM ;
Schantz, PM ;
Evans, CAW ;
Flisser, A ;
Correa, D ;
Botero, D ;
Allan, JC ;
Sarti, E ;
Gonzalez, AE ;
Gilman, RH ;
García, HH .
NEUROLOGY, 2001, 57 (02) :177-183
[9]   Symptomatic human neurocysticercosis - Age, sex and exposure factors relating with disease heterogeneity [J].
Fleury, A ;
Dessein, A ;
Preux, PM ;
Dumas, M ;
Tapia, G ;
Larralde, C ;
Sciutto, E .
JOURNAL OF NEUROLOGY, 2004, 251 (07) :830-837
[10]  
Goel U C, 1999, J Assoc Physicians India, V47, P1024